Integration of animal behaviors under stresses with different time courses

Neural Regeneration Research

Volumn 9, Issue 15, 2014, Pages 1464-1473

  Zheng, Lun ^a   Zheng, Xi Geng ^b  

^a INSTITUTE OF PSYCHOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Brain injury; Chronic unpredictable stress; Depression; Dopamine; Forced swim; Nerve regeneration; Neural regeneration; NSFC grant; Nucleus accumbens; Stress resistance; Susceptible to depression

Indexed keywords

ROPINIROLE;

ADULT; ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC UNPREDICTABLE STRESS; CONTROLLED STUDY; COPING BEHAVIOR; DEFENSE MECHANISM; DEPRESSION; DOPAMINERGIC SYSTEM; EXERCISE; FLOTATION; FORCED SWIM TEST; MALE; MOVEMENT (PHYSIOLOGY); NONHUMAN; NUCLEUS ACCUMBENS; RAT; STRESS; SUCROSE PREFERENCE TEST; TIME; WEIGHT CHANGE;

EID: 84907148198     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.139464     Document Type: Article

References (74)

1. Abdo AA, Ackermann M, Agudo I (2010) Fermi Large Area Telescope and multi-wavelength observations of the flaring activity of PKS 1510-089 between 2008 September and 2009 June. Astrophys J 721:1425-1447.
2. Agustin Zapata, Chefer VI (2009) Microdialysis in Rodents. Curr Protoc Neurosci. Chapter 7: Unit7.2
3. Antonijevic IA (2006) Depressive disorders--is it time to endorse different pathophysiologies? Psychoneuroendocrinology 31:1-15.
4. Armario A, Gavalda A, Marti O (1988) Forced swimming test in rats: effect of desipramine administration and the period of exposure to the test on struggling behavior, swimming, immobility and defecation rate. Eur J Pharmacol 158:207-212.
5. Bekris S, Antoniou K, Daskas S, Papadopoulou-Daifoti Z (2005) Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behav Brain Res 161:45-59.
6. Bertaina-Anglade V, La Rochelle CD, Scheller DKA (2006) Antidepressant properties of rotigotine in experimental models of depression. Eur J Pharmacol 548:106-114.
7. Bolkunov A, Redkozubova O, Malatynska E, van Miegem V, Vankin G, Strekalova T, Bachurin S (2009) Aging-related anhedonia in C 57 mice and effects of dimebone. J Neurochem 110:50.
8. Bowden C, Cheetham SC, Lowther S, Katona CLE, Crompton MR, Horton RW (1997) Reduced dopamine turnover in the basal ganglia of depressed suicides. Brain Res 769:135-140.
9. Cryan JF, Holmes A (2005) The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 4:775-790.
10. Cryan JF, Dalvi A, Jin SH, Hirsch BR, Lucki I, Thomas SA (2001) Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. J Pharmacol Exp Ther 298:651-657.
11. D’Aquila PS, Brain P, Willner P (1994) Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression. Physiol behav 56:861-867.
12. D’haenen HA, Bossuyt A (1994) Dopamine D2 receptors in depression measured with single photon emission computed tomography. Biol Psychiat 35:128-132.
13. Dziedzicka-Wasylewska M, Willner P, Papp M (1997) Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment. Behav Pharmacol 8:607.
14. Gendreau PL, Petitto JM, Gariepy JL, Lewis MH (1998) D2-like dopamine receptor mediation of social-emotional reactivity in a mouse model of anxiety: strain and experience effects. Neuropsychopharmacology 18:210-221.
15. Gronli J, Murison R, Fiske E, Bjorvatn B, Sorensen E, Portas CM, Ursin R (2005) Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions. Physiol Behav 84:571-577.
16. Healy E, McKeon P (2000) Dopaminergic sensitivity and prediction of antidepressant response. J Psychopharmacol 14:152.
17. Katz RJ, Roth KA, Carroll BJ (1981) Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci Biobehav Rev 5:247-251.
18. Klimek V, Schenck JE, Han H, Stockmeier CA, Ordway GA (2002) Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study. Biol Psychiat 52:740-748.
19. Laasonen-Balk T, Kuikka J, Viinam ki H, Husso-Saastamoinen M, Lehtonen J, Tiihonen J (1999) Striatal dopamine transporter density in major depression. Psychopharmacology 144:282-285.
20. Lambert G, Johansson M, Agren H, Friberg P (2000) Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch Gen Psychiatry 57:787.
21. Lawford BR, Young R, Noble EP, Kann B, Ritchie T (2006) The D2 dopamine receptor (DRD2) gene is associated with co-morbid depression, anxiety and social dysfunction in untreated veterans with post-traumatic stress disorder. Eur Psychiatry 21:180-185.
22. Levant B (1997) The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacological Rev 49:231.
23. Mathews A, MacLeod C (2005) Cognitive vulnerability to emotional disorders. Annu Rev Clin Psychol 1:167-195.
24. Meyer JH, Kr1ger S, Wilson AA, Christensen BK, Goulding VS, Schaffer A, Minifie C, Houle S, Hussey D, Kennedy SH (2001) Lower dopamine transporter binding potential in striatum during depression. Neuroreport 12:4121.
25. Millan MJ, Brocco M, Papp M, Serres F, La Rochelle CD, Sharp T, Peglion JL, Dekeyne A (2004) S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole. J Pharmacol Exp Ther 309:936.
26. Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W, Warshaw M, Maser JD (1999) Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 156:1000-1006.
27. Muscat R, Papp M, Willner P (1992) Antidepressant-like effects of dopamine agonists in an animal model of depression. Biol Psychiat 31:937-946.
28. Neumeister A, Willeit M, Praschak-Rieder N, Asenbaum S, Stastny J, Hilger E, Pirker W, Konstantinidis A, Kasper S (2001) Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychol Medicine 31:1467-1473.
29. Nierenberg AA, Wright EC (1999) Evolution of remission as the new standard in the treatment of depression. J Clin Psychiat 60:7-11.
30. Nishimura H, Tsuda A, Oguchi M, Ida Y, Tanaka M (1988) Is immobility of rats in the forced swim test “behavioral despair?”. Physiol behav 42:93-95.
31. Palermo-Neto J (1997) Dopaminergic systems: dopamine receptors. Psychiatr Clin North Am 20:705-721.
32. Papakostas GI (2006) Dopaminergic-based pharmacotherapies for depression. Eur Neuropsychopharmacol 16:391-402.
33. Papp M, Klimek V, Willner P (1994) Parallel changes in dopamine D 2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology 115:441-446.
34. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates, third ed. San Diego: Academic Press, USA.
35. Perona MTG, Waters S, Hall FS, Sora I, Lesch KP, Murphy DL, Caron M, Uhl GR (2008) Animal models of depression in dopamine, serotonin and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav Pharmacol 19: 566.
36. Petersen T, Papakostas GI, Posternak MA, Kant A, Guyker WM, Iosifescu DV, Yeung AS, Nierenberg AA, Fava M (2005) Empirical testing of two models for staging antidepressant treatment resistance. J Clin Psychopharm 25:336-341.
37. Phillips A, Barr AM (1997) Effects of chronic mild stress on motivation for sucrose: mixed messages. Psychopharmacology 134:361-362.
38. Porsolt RD, Lepichon M, Jalfre M (1977) Depression-new animal-model sensitive to antidepressant treatments. Nature 266:730-732.
39. Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379-391.
40. Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128:1314.
41. Riddle DL, Wade JB, Jiranek WA (2010) Major depression, generalized anxiety disorder, and panic disorder in patients scheduled for knee arthroplasty. J Arthroplasty 25:581-588.
42. Roy A, Karoum F, Pollack S (1992) Marked reduction in indexes of dopamine metabolism among patients with depression who attempt suicide. Arch Gen Psychiatry 49:447.
43. Roy A, Pickar D, Linnoila M, Potter WZ (1985) Plasma norepinephrine level in affective disorders: relationship to melancholia. Arch Gen Psychiatry 42:1181.
44. Schneier FR, Martinez D, Abi-Dargham A, Zea-Ponce Y, Simpson HB, Liebowitz MR, Laruelle M (2008) Striatal dopamine D2 receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings. Depress Anxiety 25:1-7.
45. Sekine Y, Suzuki K, Ramachandran PV, Blackburn TP, Ashby CR (2007) Acute and repeated administration of fluoxetine, citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. Synapse 61:72-77.
46. Shah P, Ogilvie A, Goodwin G, Ebmeier K (1997) Clinical and psychometric correlates of dopamine D2 binding in depression. Psychol Med 27:1247-1256.
47. Simon P, Panissaud C, Constentin J (1993) Anxiogenic-like effects induced by stimulation of dopamine receptors. Pharmacol Biochem Behav 45:685-690.
48. Sokoloff P, Diaz J, Foll B, Guillin O, Leriche L, Bezard E, Gross C (2006) The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS Neurol Disord Drug Targets 5:25-43.
49. Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea T, Coryell W, Warshaw M, Turvey C, Maser JD, Endicott J (2000) Multiple recurrences of major depressive disorder. Am J Psychiatry 157:229-233.
50. Steimer T, Driscoll P (2003) Divergent stress responses and coping styles in psychogenetically selected Roman high-(RHA) and low-(RLA) avoidance rats: behavioural, neuroendocrine and developmental aspects. Stress 6:87-100.
51. Steiner H, Fuchs S, Accili D (1997) D3 dopamine receptor-deficient mouse: evidence for reduced anxiety. Physiol Behav 63:137-141.
52. Strekalova T, Spanagel R, Dolgov O, Bartsch D (2005) Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice. Behav Pharmacol 16:171.
53. Strekalova T, van Miegem V, Redkozubova O, Dolgov O, Larde G, Beznosko B, Vankin G, Bachurin S (2008) Sucrose test method: facts, artifacts and application in anhedonia models with young and old C57BL/6 mice. Int J Neuropsychoph 11:128-128.
54. Sun HX, Yang YP, Shi SX, Lu Z, Zhang MY (2004) The control study of the major depression disorder comorbid with anxiety disorder in psychiatric patient. Int J Psychol 39:454-454.
55. Takamori K, Yoshida S, Okuyama S (2001) Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test. Life Sci 69:1919-1926.
56. Tanda G, Carboni E, Frau R, Dichiara G (1994) Increase of extracellular dopamine in the prefrontal cortex-a trait of drugs with antidepressant potential. Psychopharmacology 115:285-288.
57. Tannenbaum B, Tannenbaum G, Sudom K, Anisman H (2002) Neurochemical and behavioral alterations elicited by a chronic intermittent stressor regimen: implications for allostatic load. Brain Res 953:82-92.
58. Taylor BP, Bruder GE, Stewart JW, McGrath PJ, Halperin J, Ehrlichman H, Quitkin FM (2006) Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients. Am J Psychiatry 163:73.
59. Taylor DP, Riblet LA, Stanton HC, Eison AS, Eison MS, Temple DL (1982) Dopamine and antianxiety activity. Pharmacol Biochem Behav 17:25-35.
60. Tian M, Mao RR, Wang LP, Zhou QX, Cao J, Xu L (2011) Interaction between behavioral despair and addictive behaviors in rats. Physiol Behav 102:7-12.
61. Tossman U, Ungerstedt U (1986) Microdialysis in the study of extracellular levels of amino acids in the rat brain. Acta Physiol Scand 128:9-14.
62. van der Wee NJ, van Veen JF, Stevens H, van Vliet IM, van Rijk PP, Westenberg HG (2008) Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-{beta}-(4-iodophenyl)-Tropane SPECT. J Nucl Med 49:757-763.
63. Valverde O, Smadja C, Roques BP, Maldonado R (1997) The attenuation of morphine-conditioned place preference following chronic mild stress is reversed by a CCKB receptor antagonist. Psychopharmacology (Berl) 131:79-85.
64. Varga J, Domokos A, Barna I, Jankord R, Bagdy G, Zelena D (2011) Lack of vasopressin does not prevent the behavioural and endocrine changes induced by chronic unpredictable stress. Brain Res Bull 84:45-52.
65. Verbeeck WJC, Berk M, Paiker J, Jersky B (2001) The prolactin response to sulpiride in major depression: the role of the D2 receptor in depression. Eur Neuropsychopharm 11:215-220.
66. Vignisse J, Steinbusch HWM, Bolkunov A, Nunes J, Santos AI, Grandfils C, Bachurin S, Strekalova T (2011) Dimebon enhances hippocampus-dependent learning in both appetitive and inhibitory memory tasks in mice. Prog Neuro-Psychoph 35:510-522.
67. Vollenweider I, Smith KS, Keist R, Rudolph U (2011) Antidepressant-like properties of alpha2-containing GABA(A) receptors. Behav Brain Res 217:77-80.
68. Wall PM, Blanchard RJ, Yang M, Blanchard DC (2003) Infralimbic D2 receptor influences on anxiety-like behavior and active memory/attention in CD-1 mice. Prog Neuropsychopharmacol Biol Psychiatry 27:395-410.
69. Willner P, Lappas S, Cheeta S, Muscat R (1994) Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole. Psychopharmacology 115:454-462.
70. Winter C, von Rumohr A, Mundt A, Petrus D, Klein J, Lee T, Morgenstern R, Kupsch A, Juckel G (2007) Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats. Behav Brain Res 184:133-141.
71. Yang YK, Yeh TL, Yao WJ, Lee IH, Chen PS, Chiu NT, Lu RB (2008) Greater availability of dopamine transporters in patients with major depression--A dual-isotope SPECT study. Psychiatry Res 162:230-235.
72. Yarkov AV, Hanger D, Reploge M, Joyce JN (2003) Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice. Pharmacol Biochem Behav 76:551-562.
73. Yeritsyan N, Navasardyan G, Strekalova T, Avetisyan L (2003) Hypokinesia in rats leads to deficits in complex instrumental learning. Behav Pharmacol 14:S35-35.
74. Zhou FM, Liang Y, Salas R, Zhang LF, De Biasi M, Dani JA (2005) Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron 46:65-74.